Antares Pharma

We at Antares Pharma leverage our pharmaceutical and medical device expertise to develop innovative products that address needs in underserved therapeutic areas.

Our relentless pursuit of better therapies that positively affect patient lives inspires our employees to serve our customers and stakeholders every day.

Investor
Relations

ATRS

Price: $3.45
Change: +$0.01 (+0.29%)
Quotes delayed at least 15 minutes

Press Releases

  • 30 September 2021
    Antares Pharma Initiates Phase I Study for ATRS-1902 for Adrenal Crisis Rescue

  • 08 September 2021
    Antares Pharma to Participate in the H.C. Wainright 23rd Annual Global Investment Conference

  • 05 August 2021
    Antares Pharma Reports Second Quarter 2021 Financial And Operating Results

View All

Upcoming Events

  • There are no scheduled upcoming events.

View All